| Marker | Lineage (primary) | Lineage (secondary) | Function | Rationale |
| Actin (Smooth Muscle) | Myofibroblasts, smooth muscle cells | Pericytes, fibroblastic reticular cells, myoepithelial cells | Contractile cytoskeleton protein | Marks myofibroblasts and smooth muscle cells; defines stromal boundaries to aid distinction of immune from non-immune populations. |
| CD105 | Endothelial cells (high on angiogenic) | Activated macrophages, mesenchymal/stromal cells | TGF-beta co-receptor (endoglin), modulates TGF-beta signaling | Endothelial cell marker enriched on angiogenic vasculature; provides vascular spatial context for immune cell localization. |
| CD11c | DCs | Macrophages, monocytes | Integrin αX; adhesion and complement receptor | DC marker; identifies conventional dendritic cells, with expression also on macrophages and monocytes. |
| CD138 | Plasma cells | Epithelial cells, pre-B cells (bone marrow) | Transmembrane heparan sulfate proteoglycan, mediates cell-matrix adhesion and growth factor/cytokine binding | Identifies plasma cells; indicates local antibody production and mature humoral response. |
| CD19 | B cells | | B cell receptor (BCR) co-receptor, augments BCR signaling | Identifies B cells; indicates the humoral component of the infiltrate. |
| CD25 | Activated lymphocytes (T cells, B cells) | Regulatory T cells (Tregs, constitutive) | IL-2 receptor α chain, regulates T cell proliferation | Identifies activated lymphocytes and regulatory T cells (Tregs); cannot distinguish the two without FoxP3. |
| CD3 | T cells | | TCR signaling complex | Identifies total T cell populations. |
| CD326 (EpCAM) | Epithelial cells (including carcinoma cells) | | Transmembrane glycoprotein, mediates epithelial cell-cell adhesion and proliferation signaling | Identifies epithelial compartment (normal and tumor); localizes infiltrate relative to epithelium or tumor. |
| CD4 | CD4+ helper T cells | Type 2 conventional dendritic cells (cDC2s), Natural killer T (NKT) cells | MHC II co-receptor, augments TCR signaling in CD4+ T cells | Identifies helper T cells; enables CD4/CD8 ratio assessment together with CD8a and CD8b. |
| CD44 | Activated/memory T cells | Myeloid cells, B cells (upregulated on activated), most other leukocytes, stromal cells, endothelial cells, epithelial cells | Hyaluronan receptor, mediates cell adhesion and migration | Distinguishes effector/memory (CD44hi) from naïve (CD44lo) T cells; broadly expressed, interpret with co-expression context. |
| CD45 | All nucleated hematopoietic cells | | Receptor-type tyrosine phosphatase, regulates antigen receptor and cytokine signaling | Universal leukocyte detection to separate all immune cells from non-immune tissue. |
| CD45R (B220) | B cells | Activated T cells, plasmacytoid dendritic cells (pDCs), NK cells (subset) | CD45 high-molecular-weight isoform; receptor-type tyrosine phosphatase, regulates B cell receptor signaling | Supports B cell identification; together with CD19 discriminates B cells (CD19+B220+) from pDCs (CD19−B220+). |
| CD68 | Macrophages | Monocytes (low-level), monocyte-derived DCs | Lysosomal/endosomal glycoprotein, phagocytic metabolism | Pan-macrophage marker; primary marker for identifying myeloid innate immune cells in tissue. |
| CD8a | CD8+ cytotoxic T cells | Type 1 conventional dendritic cells (cDC1s), intestinal intraepithelial lymphocytes (IELs) | MHC I co-receptor, augments TCR signaling in CD8+ T cells | Identifies cytotoxic T cells as key adaptive immune effectors. |
| CD8b | CD8+ cytotoxic T cells | | MHC I co-receptor (T cell-specific) | Together with CD8a confirms cytotoxic T cells; excludes CD8a+ non-T cell populations, such as conventional type 1 dendritic cells (cDC1s). |
| F4/80 | Macrophages (high on tissue-resident) | Eosinophils (low-level), monocytes (low-level) | EGF-TM7 adhesion receptor (EMR1/ADGRE1) | Macrophage marker with high expression on tissue-resident populations; complements CD68 to distinguish resident from recruited macrophages. |
| Gr-1 | Neutrophils | | Ly6G = GPI-anchored cell-surface protein | Neutrophil-specific marker; identifies neutrophilic innate inflammatory infiltrate. |
| Ki-67 | Proliferating cells | | Nuclear protein expressed in all active cell cycle phases (G1, S, G2, M), absent in quiescent (G0) cells | Measures proliferative activity across immune, stromal, and tumor cell populations. |
| MHC Class II | Antigen-presenting cells (APCs): dendritic cells (DCs), B cells | Activated macrophages, monocytes (inducible) | Antigen presentation to CD4+ T cells | Marks APCs; reflects local antigen presentation capacity. |
| NK1.1 | Natural killer (NK) cells | NKT cells (subset), some activated T cells | Activating C-type lectin-like receptor (NKR-P1C), triggers NK cell activation and cytotoxicity | Identifies NK cells and NKT cells; strain-dependent expression (present in C57BL/6, absent in BALB/c and other strains). |
| Pan-Cytokeratin | Epithelial cells (including carcinoma cells) | | Intermediate filament proteins, provide structural integrity to epithelial cells | Broadly marks epithelial compartment (normal and tumor); localizes infiltrate relative to epithelium or tumor. |
| Podoplanin | Lymphatic endothelial cells | Stromal fibroblasts (including fibroblastic reticular cells), certain epithelial populations (tissue-dependent) | Transmembrane sialoglycoprotein, regulates cell migration and lymphatic vessel integrity | Lymphatic endothelial cell marker; also labels stromal fibroblasts, providing tissue architectural context for immune cell distribution. |